Piperacillin

Common Uses

Piperacillin is prescribed to treat moderate to severe infections caused by susceptible bacteria. It is commonly used for the following conditions:

• Respiratory infections: Including pneumonia and other infections of the lower respiratory tract.
• Abdominal infections: Such as peritonitis and other infections within the stomach area.
• Skin infections: Including serious infections of the skin and the tissues underneath.
• Urinary tract infections: Specifically for complicated or severe cases.
• Gynecologic infections: Including pelvic inflammatory disease and infections following surgery.
• Bone and joint infections: To treat bacterial growth in the skeletal system.
• Septicemia: Serious infections that have spread into the bloodstream.

This medication is only effective against bacterial infections and will not work for viral infections like the common cold or flu. In many clinical settings, piperacillin is administered in combination with tazobactam to help the antibiotic work more effectively against certain resistant bacteria.

How Piperacillin Fights Infection

Piperacillin belongs to a class of medications known as penicillin-type antibiotics. It works by interfering with the ability of bacteria to form cell walls. The cell wall is a protective outer layer that bacteria need to survive and multiply. By weakening this wall, piperacillin causes the bacteria to rupture and die.

Protection from Bacterial Resistance

In many cases, piperacillin is combined with another medication called tazobactam. This is because some bacteria produce enzymes called beta-lactamases that can destroy piperacillin before it can work. Tazobactam blocks these enzymes, allowing the piperacillin to effectively kill the bacteria.

Scope of Use

This medication is specifically designed to target bacterial infections. It does not have any effect on viruses, such as those that cause the flu or the common cold.

Common Side Effects

• Nausea or vomiting
• Diarrhea or constipation
• Headache
• Trouble sleeping
• Mild skin rash or itching
• Pain, redness, or swelling at the injection site

Serious Side Effects

Seek medical help right away if you experience any of the following serious symptoms:

• Signs of a severe allergic reaction, such as hives, swelling of the face or throat, or difficulty breathing
• Severe stomach cramps and watery or bloody diarrhea, which may occur during treatment or several months after the last dose
• Severe skin reactions, including blistering, peeling, or a widespread red or purple rash
• Unusual bleeding or bruising
• Seizures or tremors
• Fever, sore throat, or other signs of a new infection
• Confusion or hallucinations

Hypersensitivity and Allergic Reactions

Serious and occasionally fatal hypersensitivity (anaphylactic) reactions have been reported. These reactions are more likely to occur in individuals with a history of sensitivity to multiple allergens. Before starting treatment, a history of previous hypersensitivity reactions to penicillins, cephalosporins, or other allergens is typically assessed. If an allergic reaction occurs, the medication is discontinued.

Severe Cutaneous Adverse Reactions

Piperacillin may cause severe skin reactions, including Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), drug reaction with eosinophilia and systemic symptoms (DRESS), and acute generalized exanthematous pustulosis (AGEP). If a rash or other skin symptoms develop, the medication is usually stopped.

Neurological Effects

Neurological complications, such as seizures, may occur, especially in patients with impaired kidney function who receive high doses of the drug.

Gastrointestinal Concerns

Clostridioides difficile-associated diarrhea (CDAD) has been reported with nearly all antibacterial agents, including piperacillin. This condition can range in severity from mild diarrhea to fatal colitis. It is caused by the overgrowth of C. difficile when the normal flora of the colon is altered.

Hematologic and Electrolyte Monitoring

• Bleeding: Some patients may experience bleeding manifestations or changes in blood clotting tests, particularly those with kidney failure.
• Blood Counts: Long-term therapy may lead to low white blood cell counts (leukopenia or neutropenia), necessitating periodic monitoring of blood cell levels.
• Potassium Levels: Low potassium levels (hypokalemia) may occur, and electrolyte monitoring is often recommended for patients with low potassium reserves or those receiving concurrent medications that lower potassium.

Drug Resistance

Using piperacillin in the absence of a proven or strongly suspected bacterial infection is unlikely to provide benefit and increases the risk of developing drug-resistant bacteria.

Pregnancy

There is limited information regarding the use of piperacillin in pregnant women. While animal studies have not demonstrated a risk of birth defects or harm to the fetus, adequate and well-controlled studies in humans are not available. Piperacillin is known to cross the placenta. Because of the lack of human data, healthcare providers generally prescribe this medication during pregnancy only if the potential benefits outweigh the potential risks to the fetus.

Breastfeeding

Piperacillin is excreted into breast milk in low concentrations. The specific effects of this exposure on a nursing infant are currently unknown. Individuals who are breastfeeding or planning to breastfeed should consult with their healthcare provider to discuss the potential risks and benefits of using this medication while nursing.

Available Forms

Piperacillin is administered directly into a vein (intravenously) and is available in several preparation formats:

• Powder for Injection: This form is provided in vials or pharmacy bulk packages and must be mixed with a sterile liquid by a healthcare professional before it can be administered.
• Premixed Solution: This version is supplied in single-dose containers already mixed with a diluent and is ready for immediate infusion.
• Combination Products: Piperacillin is most commonly available in a fixed-ratio combination with tazobactam, which is also provided as a powder for injection or a premixed solution.

FDA Approval Status

Piperacillin is an FDA-approved antibiotic belonging to the penicillin class. It is indicated for the treatment of various systemic infections, including those affecting the respiratory tract, abdomen, and skin. While originally approved as a standalone agent, it is now most commonly used in a fixed-dose combination with tazobactam, a beta-lactamase inhibitor.

Susceptibility Breakpoints

The FDA periodically reviews and updates susceptibility breakpoints for antibiotics. For piperacillin and tazobactam, the FDA has provided specific guidance on breakpoints for Pseudomonas aeruginosa to ensure that laboratory testing accurately reflects the drug's effectiveness against this specific pathogen.

Regulatory Oversight

Piperacillin is classified as a prescription-only medication. It does not carry a Boxed Warning, and there are no specific Risk Evaluation and Mitigation Strategies (REMS) mandated by the FDA for its use. Regulatory information focuses on ensuring proper dosing and monitoring for hypersensitivity reactions common to the penicillin class.

FDA-Approved Indications

Piperacillin is a penicillin-type antibiotic approved by the FDA to treat various serious bacterial infections. It is frequently administered in combination with tazobactam, a beta-lactamase inhibitor, to expand its effectiveness against certain resistant bacteria.

Approved uses for piperacillin and its combinations include:

• Intra-abdominal infections: Including complicated appendicitis and peritonitis.
• Skin and skin structure infections: Such as cellulitis, cutaneous abscesses, and diabetic foot infections.
• Respiratory tract infections: Including community-acquired and hospital-acquired (nosocomial) pneumonia.
• Gynecological infections: Including postpartum endometritis and pelvic inflammatory disease.

Regulatory Status

The FDA first approved piperacillin in the 1980s. While it was originally available as a standalone product, it is now most commonly used in the FDA-approved combination of piperacillin and tazobactam. This combination is approved for use in both adult and pediatric patients, though age requirements vary depending on the specific type of infection being treated.

Administration and Safety

This medication is approved for administration by a healthcare professional via intravenous infusion or intramuscular injection. The FDA-approved labeling includes specific precautions for patients with a history of allergic reactions to penicillin or cephalosporin antibiotics, as well as dosage adjustments for patients with renal impairment.